scholarly article | Q13442814 |
P356 | DOI | 10.1177/0960327111433185 |
P698 | PubMed publication ID | 22318306 |
P2093 | author name string | M Inci | |
C Yilmaz | |||
N Yilmaz | |||
M Tutanc | |||
S Ates | |||
T Ozgur | |||
Fatmagul Basarslan | |||
V Arica | |||
S Buyukbas | |||
V K Motor | |||
P433 | issue | 7 | |
P304 | page(s) | 726-733 | |
P577 | publication date | 2012-02-08 | |
P1433 | published in | Human & Experimental Toxicology | Q1636500 |
P1476 | title | Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats | |
P478 | volume | 31 |
Q38098184 | A review on the role of quinones in renal disorders |
Q35993007 | Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells |
Q55268265 | Black Seed (Nigella Sativa) and its Constituent Thymoquinone as an Antidote or a Protective Agent Against Natural or Chemical Toxicities. |
Q36452357 | Commentary: Continuous infusion of vancomycin in neonates: to use or not to use remains the question. |
Q37287667 | Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats |
Q35683026 | Mechanisms of Thymoquinone Hepatorenal Protection in Methotrexate-Induced Toxicity in Rats |
Q26776397 | Mitochondria: a new therapeutic target in chronic kidney disease |
Q39169974 | Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials. |
Q30569251 | Prevention of vancomycin induced nephrotoxicity: a review of preclinical data |
Q43943412 | Protective effect of thymoquinone against cisplatin-induced ototoxicity |
Q42363810 | Therapeutic Potential and Pharmaceutical Development of Thymoquinone: A Multitargeted Molecule of Natural Origin |
Q87089534 | Thymoquinone protects end organs from abdominal aorta ischemia/reperfusion injury in a rat model |
Search more.